Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 98 results found. Search for [ bulk drug manufacturing in India ]

Results 1 to 21 of 98
Associated Press
March 3, 2021
White House press secretary Jen Psaki also announced Tuesday that the federal government was increasing supply of the Moderna and Pfizer vaccines to states next week to 15.2 million doses per week, up from 14.5 million previously


BusinessToday.In
February 1, 2021
Budget 2021 expectations: The pharma sector is among those sectors which would have big expectations from the Budget. The sector was in focus in 2020 as the COVID-19 pandemic ravaged lives and economies across the world


Shuchi Ray | K Baskar | Vinod Parashar
January 29, 2021
Similar to the anticipation for the COVID-19 vaccination, the healthcare industry is also looking forward to an incentive booster in the upcoming Union Budget


Joe C Mathew
January 22, 2021
While Aurobindo Pharma has committed an investment of Rs 3,039 crore to set up production facilities for three eligible products, Kinvan will invest Rs 447.17 crore to build 300 MT capacity plant to produce Clavulanic Acid


Joe C Mathew
New Delhi, December 9, 2020
Centre has announced two schemes to reduce import dependence in medicine manufacturing. Will they work this time?


PB Jayakumar
November 12, 2020
Covishield has been developed at the Serum Institute of India's Pune laboratory with a master seed from Oxford University/Astra Zeneca. The vaccine made in the UK is currently being tested in large efficacy trials in UK, Brazil, South Africa and USA


Joe C Mathew
September 26, 2020
There is a strong chance that China may dump these products at a much lesser price once India starts production; unless countered with very quick anti-dumping measures, it may turn production of such items unsustainable for Indian industry, says BR Sikri, Chairman of Federation of Pharma Entrepreneurs


PB Jayakumar
New Delhi, September 1, 2020
GMM Pfaudler has made strategic acquisitions, diversified its product basket and invested in new capacities with an eye on long-term growth


PB Jayakumar
New Delhi, September 1, 2020
Alkyl Amines Chemicals, the manufacturer and supplier of specialty chemicals for pharmaceutical and agrochemical sectors, has consistently remained ahead of competition for the last few years. New products and expansion plans are set to propel its growth further


BusinessToday.In
August 19, 2020
Jairam Ramesh says India depends on China for most of its active pharmaceutical ingredients, and during coronavirus-induced lockdown in May and June, API prices shot up steeply, exposing India's vulnerabilities


BusinessToday.In
August 1, 2020
Currently, India imports 68 per cent APIs and more than 90 per cent antibiotics from China. the country's pharmaceutical industry is the world's third-largest in terms of volume


Joe C Mathew
New Delhi, July 27, 2020
In a presentation made at the official launch of these schemes, the department of pharmaceuticals, Ministry of Chemicals and Fertilisers points out that the schemes when operationalised will result in import substitution and drug security for the country


Joe C Mathew
July 23, 2020
Bajaj said that while India's GDP will shrink this year, it will be a 'V' shaped recovery next year unless COVID-19 hits the country very hard, which is highly unlikely


BusinessToday.In
July 22, 2020
Coronavirus (COVID-19) Vaccine News Latest Updates: Dr Cyrus Poonawalla, Chairman of the Poonawalla Group, says a just a few million doses of the potential COVID-19 vaccine will not be enough and the company intends to manufacture around 1 billion doses after getting all the necessary approvals


Sumant Banerji
June 22, 2020
Centre to ensure Chinese goods do not enter India via other countries like Taiwan, Singapore, Malaysia and Indonesia


PTI
June 21, 2020
The IEX data showed that both non-solar and solar RECs witnessed higher supply, with sell bids exceeding buy bids. There were buy bids for over 2.8 lakh RECs against sell bids for over 31 lakh RECs in May this year


Joe C Mathew
New Delhi, June 15, 2020
What is more interesting is that the incentive - reimbursement of 10 to 20 percent of the net incremental sales turnover for the first four years, depending on the category you fall - will be calculated only on the revenue earned from domestic sales with a ceiling on the quantity that can be sold


Joe C Mathew
June 3, 2020
The government strategy is expected to reduce dependence on China and be self reliant on the production of live saving and critical medicines throughout its production chain


Joe C Mathew
New Delhi, June 2, 2020
Bulk drugs and intermediates that will be covered under the scheme are meant to produce vitamins, anti-TB drugs, anti-infectives, antibiotics, steroids, etc


Joe C Mathew
New Delhi, May 27, 2020
In the middle of the current pandemic, India has emerged as a credible supplier of essential medicines


PAGES 1 OF 5  12345